Rotech Healthcare

Topic: Rotech

Managing Both COPD and Heart Failure? What You Need to Know

Living with one chronic condition is hard enough. Managing two that affect both your breathing and your heart can add another layer of complexity to everyday life.

COPD (chronic obstructive pulmonary disease) and heart failure often occur together, and the overlap can make symptoms harder to recognize and manage. Research shows that up to one-third of people with heart failure also have COPD,1 and when these conditions coexist, they can intensify each other in ways that aren’t always obvious.

With a clear understanding of how COPD and heart failure interact, and a care plan designed to address both, it’s possible to manage symptoms at home and reduce unexpected hospital visits.

At Rotech Healthcare, we specialize in helping patients living with COPD and heart failure get the equipment, education, and ongoing support they need to stay healthier and out of the hospital. This article will help you understand how these conditions are connected, what symptoms to watch for, and how we can help you take control of your care.


Why COPD and Heart Failure Often Go Together

If you have COPD and heart failure, you might wonder: why me? Why both? The truth is, these two conditions share so many risk factors and pathways that having one significantly increases your risk of developing the other. This isn’t bad luck — it’s biology.

Shared Risk Factors

COPD and heart failure often develop from the same underlying causes:2

Risk Factor How It Affects You
Smoking history Damages both lung tissue and blood vessels, contributing to both conditions
Aging Natural decline in heart and lung function increases vulnerability
Chronic inflammation Ongoing inflammation throughout the body affects both the heart and lungs
Sedentary lifestyle Reduced physical activity weakens both cardiovascular and respiratory systems
Air pollution and environmental exposures Long-term exposure damages lung tissue and promotes cardiovascular disease

How Each Condition Makes the Other Worse

COPD and heart failure create a cycle that can be difficult to break:

COPD puts extra strain on your heart. When your lungs don’t work efficiently, your body has to work harder to get enough oxygen. This extra effort strains the heart over time, potentially leading to heart failure, especially affecting the right side of the heart.

Heart failure makes breathing harder. When your heart can’t pump effectively, fluid can build up in your lungs. This fluid makes it even harder to breathe, worsening the symptoms you already experience from COPD.

The result is that each condition accelerates the progression of the other, which is why managing both together, rather than treating them separately, is so important.


Sporty senior man walking outdoors with headphones on and coughing, out of breath

Recognizing Symptoms When You Have Both Conditions

One of the most frustrating aspects of living with COPD and heart failure is that the symptoms overlap so much. It can be genuinely difficult to know which condition is causing your discomfort on any given day.

Symptoms Common to Both Conditions

  • Shortness of breath — especially during activity or when lying flat
  • Fatigue and low energy — feeling exhausted even after rest
  • Swelling in legs, ankles, or feet — more common with heart failure, but can occur with both
  • Difficulty sleeping — particularly when lying down
  • Reduced ability to exercise — getting winded more easily than before
  • Coughing — may be dry or produce mucus

Why Tracking Matters

Because these symptoms overlap, it’s critical to monitor changes rather than guess at the cause. A symptom that’s “normal” for your COPD might actually signal worsening heart failure, or vice versa.

This is exactly why working with a provider who understands both conditions makes such a difference. Tracking your symptoms over time helps you and your care team identify patterns, catch problems early, and adjust your treatment before small issues become emergencies.


How Rotech Supports Patients with COPD and Heart Failure with COPDBridge™

Managing two complex conditions at home requires more than just equipment delivery. It requires education, regular monitoring, and a care team that stays connected with you over time.

At Rotech Healthcare, we’ve built programs specifically designed to help patients like you manage their conditions at home, reducing hospitalizations and improving quality of life.

COPDBridge™: Intensive Support in the Critical First 30 Days

The weeks immediately following a hospital discharge are the most vulnerable time for COPD patients. Research shows that more than 20% of patients hospitalized for COPD are readmitted within 30 days.3 That’s why we created COPDBridge™.

COPDBridge™ is a comprehensive 30-day program designed to help you transition safely from hospital to home and stay out of the hospital.

What’s included:

  • Weekly visits with a respiratory therapist — including physical assessments, nutrition support, medication review, and smoking cessation resources if applicable
  • Daily monitoring and data collection — tracking your condition so changes are caught early
  • COPDBridge 30-Day Journal — a structured way to record your symptoms, track your progress, and identify patterns
  • Online patient education — accessible from any device, so you can learn at your own pace
  • Follow-up documentation — sent directly to your hospital and physician, keeping your entire care team informed

Learn More About COPDBridge™

The goal: Help you recognize the early signs of an exacerbation, follow your COPD action plan, and get treatment before things get worse.

CarePLUS™: Ongoing Support Beyond the First 30 Days

While COPDBridge focuses on the critical post-discharge period, CarePLUS™ ensures you have everything you need for long-term success at home.

CarePLUS™ provides:

  • Overnight oximetry testing — monitoring your oxygen levels while you sleep to catch problems that daytime measurements miss
  • Home medical equipment — including hospital beds, wheelchairs, ventilators, oxygen supplies, and other equipment tailored to your needs
  • Care coordination — our team keeps your physicians and care team informed about how you’re doing at home
  • Ongoing troubleshooting and support — care coordinators available to answer questions, solve problems, and ensure your equipment is working properly

Think of CarePLUS as an extension of your care team — eyes and ears in your home that help catch issues before they become emergencies.

Learn More About CarePLUS™


Older man taking his medication at home as prescribed

Practical Tips for Managing Both Conditions at Home

While professional support is essential, there’s also a lot you can do every day to manage COPD and heart failure together.

Monitor Your Symptoms Daily

Pay attention to changes in your breathing, energy levels, and swelling. Keep a simple log, even just a few notes each day can help you spot patterns and give your care team valuable information.

Watch for warning signs that need attention:

  • Sudden increase in shortness of breath
  • New or worsening swelling in legs or ankles
  • Rapid weight gain (more than 2-3 pounds in a day or 5 pounds in a week)
  • Increased coughing or change in mucus color
  • Feeling unusually tired or confused

Take Medications as Prescribed

Both COPD and heart failure often require multiple medications. Take them exactly as prescribed, and don’t stop or change doses without talking to your doctor first. If you’re having trouble keeping track, ask your pharmacist about pill organizers or medication management tools.

Stay as Active as Safely Possible

It might seem counterintuitive when breathing is difficult, but gentle, regular physical activity can strengthen both your heart and lungs over time. Talk to your doctor about what level of activity is safe for you, and consider pulmonary rehabilitation if it’s available in your area.

Follow Dietary Guidelines

Both conditions benefit from limiting sodium intake, which can reduce fluid retention and ease the strain on your heart and lungs. Your care team can provide specific guidance based on your situation.

Don’t Skip Follow-Up Appointments

Regular check-ins with your doctors allow them to catch changes early and adjust your treatment plan as needed. If getting to appointments is difficult, ask about telehealth options or whether your home health provider can help coordinate care.


Man with supplemental oxygen on flexing outdoors in the woods

Remember, You’re Not Managing This Alone

Managing COPD and heart failure is challenging, but doable, especially when you partner with the right provider. It’s important to be proactive with your care, and be your own advocate. Rotech is here to help with our COPDBridge and CarePLUS programs, which focus on improving outcomes and making sure you have the equipment you need at home to manage your conditions. Contact us to learn more about how we can help you.


Frequently Asked Questions About COPD and Heart Failure

Why do COPD and heart failure often occur together?

COPD and heart failure share many risk factors, including smoking, aging, and chronic inflammation. Additionally, COPD puts extra strain on the heart over time because the body works harder to get enough oxygen. Heart failure, in turn, can cause fluid buildup in the lungs, worsening breathing problems. This creates a cycle where each condition accelerates the other.

How common is it to have both COPD and heart failure?

Very common. Research indicates that up to 30-40% of patients with heart failure also have COPD,1 and vice versa. Having both conditions together is associated with worse outcomes and more frequent hospitalizations, which is why coordinated management is so important.

How can I tell which condition is causing my symptoms?

This is one of the most challenging aspects of living with both conditions, since symptoms like shortness of breath, fatigue, and swelling occur with both COPD and heart failure. Tracking your symptoms daily helps identify patterns. Working with a provider like Rotech, who can monitor your oxygen levels and coordinate with your care team, makes it easier to determine what’s happening and respond appropriately.

What is the COPDBridge™ program?

COPDBridge™ is Rotech’s 30-day intensive support program for COPD patients transitioning from hospital to home. It includes weekly respiratory therapist visits, daily monitoring, patient education, a symptom-tracking journal, and direct communication with your care team. The goal is to reduce hospital readmissions by helping you catch problems early and manage your condition effectively at home.

What is CarePLUS™ and how does it help?

CarePLUS™ is Rotech’s ongoing support program that extends beyond the first 30 days. It includes overnight oximetry testing, home medical equipment supply, care coordination with your physicians, and responsive support from care coordinators. CarePLUS acts as an extension of your care team, helping identify issues before they become emergencies.

Can both conditions be managed at home?

Yes. With proper equipment, education, monitoring, and support, most patients with COPD and heart failure can manage their conditions at home. The key is having a comprehensive care plan and working with a provider who understands both conditions and can coordinate your care effectively.

What symptoms should I report to my doctor immediately?

Contact your care team or seek medical attention if you experience sudden worsening of shortness of breath, rapid weight gain (more than 2-3 pounds in a day), new or increased swelling, chest pain, confusion, or symptoms that don’t respond to your usual treatments. Early intervention can often prevent hospitalization.

Does insurance cover home respiratory therapy programs?

Most insurance plans, including Medicare, cover home respiratory equipment and related services for patients with qualifying diagnoses. Rotech works with most major insurance providers and can help you understand your coverage options.


References

  1. Axson, E. L., Sundaram, V., Bloom, C. I., Bottle, A., Cowie, M. R., & Quint, J. K. (2018). Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol. BMJ Open, 8(6), e023058. https://doi.org/10.1136/bmjopen-2018-023058
  2. de Miguel-Díez, J., Chancafe Morgan, J., & Jimenez-Garcia, R. (2013). The association between COPD and heart failure risk: A review. International Journal of Chronic Obstructive Pulmonary Disease, 8, 305. https://doi.org/10.2147/copd.s31236
  3. Fortis, S. (2024). Why Home-NIV Should Begin in the Hospital, Not at Home. American Journal of Respiratory and Critical Care Medicine, 210(3), 260–261. https://doi.org/10.1164/rccm.202401-0214vp

Rotech Healthcare Partners with Signifier Medical Technologies to Provide Revolutionary Obstructive Sleep Apnea Therapy Device

Orlando, FL — November 25, 2024 — Rotech Healthcare, a leader in home respiratory and medical equipment, is thrilled to announce an agreement for a supplier partnership with Signifier Medical Technologies Limited. This partnership will introduce the FDA-approved eXciteOSA® device to payers, healthcare providers, and patients, marking a significant advancement in the treatment of mild to moderate Obstructive Sleep Apnea (OSA).

The eXciteOSA® device, developed by Signifier Medical Technologies, represents a pioneering approach to OSA therapy. Unlike traditional solutions, eXciteOSA® is designed for daytime use, targeting the root causes of OSA with a user-friendly and non-invasive treatment method. Neuromuscular electrical stimulation (NMES) tones tongue muscles to maintain an open airway during sleep, improving users’ sleep quality and overall health.

“Partnering with Signifier Medical Technologies is an exciting step forward for us,” said Robin Menchen, Chief Executive Officer at Rotech Healthcare. “The eXciteOSA® device offers an easy-to-use and effective treatment for OSA, and we are proud to bring this cutting-edge technology to our network of payers and healthcare providers, ultimately benefiting countless patients.”

“eXciteOSA® is an innovative and promising technology that is helpful for some patients with OSA,” said Professor Atul Malhotra, MD, a renowned expert recently honored with the 2024 Sleep and Respiratory Neurobiology Lifetime Achievement Award by the American Thoracic Society. “The data suggest that OSA patients have issues with endurance in the upper airway muscles, a problem directly addressed by this technology. OSA is thought to affect up to 1 billion people worldwide. Although CPAP is effective for some patients, many benefit from alternative therapies such as eXciteOSA. eXciteOSA® can serve as a standalone treatment for snoring and for certain patients with mild OSA, while also being a useful adjunctive therapy alongside other interventions such as weight loss.”

“Rotech Healthcare’s extensive reach and commitment to patient care make them an ideal partner for us,” said Professor Akhil Tripathi, Co-Founder and Managing Director of Signifier Medical Technologies. “Together, we can ensure that patients suffering from OSA have access to innovative and effective treatment options.”

Earlier this year, CMS established a new HCPCS code for the eXciteOSA® device.  The device was also approved for coverage by Medicaid in South Carolina.

This partnership underscores Rotech Healthcare’s ongoing commitment to enhancing patient care through innovative medical solutions. The eXciteOSA® device will be available through Rotech Healthcare’s comprehensive distribution channels, ensuring broad accessibility for those in need.

About Rotech Healthcare: Rotech Healthcare is a premier provider of home respiratory and medical equipment, dedicated to improving the quality of life for patients through superior care and innovative solutions. With a nationwide network, Rotech Healthcare offers a wide range of services and products designed to meet the diverse needs of its home care patients.

About Signifier Medical Technologies Limited: Signifier Medical Technologies Limited is at the forefront of medical innovation, specializing in the development of advanced therapy solutions for OSA. Their flagship product, the eXciteOSA® device, reflects their commitment to improving patient outcomes through state-of-the-art technology.

Rotech Plans Seamless Leadership Transition

ORLANDO, Fla. – Effective January 1, 2024, Tim Pigg has transitioned from the Chief Executive Officer (CEO) to Executive Chairman of the Board.  He has served in the CEO position for the past 10 years and various other leadership positions for a total of 40 years with Rotech.

In his new role, Pigg will continue to invest his time in the company’s major strategies and lobbying efforts.

Robin Menchen has advanced from the President and Chief Operating Officer (COO) to President and CEO for Rotech Healthcare Inc. (Rotech).  Menchen has also served as the company’s Chief Administrative Officer (CAO), VP of Compliance and various other leadership roles over the past 30 years.

“I have worked closely with Robin for over 2 decades and she has consistently demonstrated exceptional leadership, vision, and a deep understanding of Rotech’s goals and values. I am confident Robin, with the continued support of the executive team, will continue to drive our company’s success,” Pigg said, “It has been an honor and a privilege to serve as Rotech’s CEO, and I will cherish the memories and relationships I have forged during my tenure.”

Rotech is one of the largest providers of home medical equipment and related products and services (collectively referred to as “HME products and services”) in the United States, with a comprehensive offering of oxygen, other respiratory therapy equipment, wound care equipment and supplies, and diabetes devices and supplies. The Company provides HME products and services in 50 states through approximately 300 operating locations.

Philips Respironics Device Recall

Philips Respironics announced a voluntary recall for certain CPAP, BiLevel PAP and Ventilator Devices manufactured prior to April 21, 2021.

This recall is due to two issues related to the polyester-based polyurethane (PE-PUR) sound abatement foam used in these devices.

Philips is notifying customers and users of affected devices that they will replace the current sound abatement foam with a new material that is not affected by this issue. Affected devices currently will be either replaced with a new or refurbished unit that incorporates the new material, or repaired to replace the sound abatement foam in customer units.

For more information on the Recall Notice, a complete list of impacted products, and more information, visit philips.com/src-update .

Rotech is committed to providing safe CPAP/BiPAP and Ventilator equipment for all patients.

Rotech Completes Refinancing

New 5-year $425 million Credit Facility

ORLANDO, Fla.— On December 17, 2020, Rotech Healthcare Inc. (Rotech) entered into a new $425 million amended and restated credit agreement with a diversified group of lenders including Truist Bank, as Administrative Agent, Swingline Lender and Issuing Bank, Citizens Bank, Fifth Third Bank, National Association, and Regions Bank, as Co-Syndication Agents, Truist Securities, Inc., Citizens Bank, Fifth Third Bank, National Association, and Regions Bank, as Joint Lead Arrangers and Joint Bookrunners and Manufacturers and Traders Trust Company, as Documentation Agent (the “Credit Agreement”).

The Credit Agreement is comprised of a $335 million five year term loan, a $15 million revolving credit facility and a $75 million acquisition credit facility. The proceeds of this transaction were used to pay a $100 million special dividend to the Company’s parent as well as provide a $75 million acquisition credit facility to support the Company’s continued strategy to grow through strategic acquisitions. At close, the Company has in excess of $75 million in cash and undrawn revolver.

“I am pleased with the completed refinancing and want to thank Truist, Regions, Fifth Third, Citizens and M&T for leading this effort,” said Tim Pigg, Chief Executive Officer of Rotech. “This new credit agreement provides Rotech with sufficient capital over the next five years to continue our growth strategies as well as to provide a $100 million special dividend to our holding company.”

Mr. Pigg went on to say, “2020 has been a very challenging and successful year for Rotech as we continue to focus on being part of the solution to the COVID-19 Public Health Emergency. We have focused on assisting hospitals discharge patients as soon as practical to keep as many beds available as possible. As a result, we have continued to grow all our major product lines and improve profitability by controlling costs and leveraging our fixed cost infrastructure. In addition, we continue to enhance our state of the art technology platforms including our new, first in the industry, patient portal and mobile app.” Mr. Pigg went on to say, “the expanded $75 million acquisition credit facility will allow Rotech to continue its acquisition strategy leveraging our clinical programs designed to help patients to remain in their homes and avoid costly inpatient care. We have successfully acquired and integrated over 65 businesses over the last four years.”

Rotech is one of the largest providers of home medical equipment and related products and services (collectively referred to as “HME products and services”) in the United States, with a comprehensive offering of oxygen, other respiratory therapy equipment and services and wound care equipment and supplies. The Company provides HME products and services in 50 states through approximately 300 operating locations.

For billing questions or insurance updates, click the NEW chat icon in the lower right — we’re here to help!